Submitted by Anonymous (not verified) on 25 September 2026 - 9:28
Human medicines European public assessment report (EPAR): Skytrofa (previously Lonapegsomatropin Ascendis Pharma), lonapegsomatropin, Date of authorisation: 11/01/2022, Revision: 7, Status: Authorised
Source: